Is fetal pulse oximetry a waste of time? Riveting results from an important trial presented at the 26th annual SMFM meeting in Miami in February suggest just that?and seemingly shatter the whole premise behind fetal pulse oximetry: that it might either improve perinatal outcome or lower cesarean delivery rates.
Is fetal pulse oximetry a waste of time? Riveting results from an important trial presented at the 26th annual SMFM meeting in Miami in February suggest just that-and seemingly shatter the whole premise behind fetal pulse oximetry: that it might either improve perinatal outcome or lower cesarean delivery rates.
The practice of using fetal oximetry to measure fetal oxygen saturation during labor was already on pretty shaky ground when National Institute of Child Health and Human Development (NICHD) MFMU Network researchers decided it was time to assess the device's effectiveness in a large, prospective well-designed trial. After all, in the wake of the FDA's conditional approval of the oximetry device in May 2000, the dystocia rate had unexpectedly and inexplicably doubled, pointed out Bethesda investigator, S. L. Bloom. Moreover, in a subsequent ACOG Committee Opinion, the organization had refused to endorse the new technology.
Aiming to assess the technology in "a real-world setting," the researchers set out to measure whether a clinician's awareness of fetal oxygen saturation values used in conjunction with continuous electronic fetal monitoring is associated with the condition of the newborn or linked to a significant change in the overall cesarean delivery rate (that includes C/S performed specifically for dystocia and nonreassuring fetal heart rate).
Bloom SL for the NICHD MFMU Network, Bethesda, Maryland. The MFMU Network randomized trial of fetal pulse oximetry. Am J Obstet Gynecol. 2005;193(6 suppl):S2. (Abstract 1)
Cesarean delivery reduces mortality risk in preterm breech births
December 2nd 2024In a recent study, infants born very preterm or extremely preterm had reduced odds of mortality when cesarean delivery was chosen as the mode of delivery, without a notable increase in any morbidity risk.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More
Major congenital malformations not linked to first trimester tetracycline use
November 20th 2024A large population-based study found that first-trimester tetracycline exposure does not elevate the risk of major congenital malformations, though specific risks for nervous system and eye anomalies warrant further research.
Read More
No link found between prenatal cannabis use and childhood developmental delay
November 5th 2024In a recent study, offspring of women with cannabis use in early pregnancy confirmed by self-report or toxicology test were not at an increased risk of childhood early developmental delay up to the age of 5.5 years.
Read More
Prenatal cannabis use not linked to offspring ASD development
November 1st 2024In a recent study, adjustments for maternal characteristics mediated the association between maternal prenatal cannabis use and offspring autism spectrum disorder, indicating no statistically significant increase in risk.
Read More